期刊文献+

孟鲁斯特联合丙酸氟替卡松吸入治疗儿童感染后咳嗽的疗效观察 被引量:7

下载PDF
导出
摘要 目的评价孟鲁斯特联合丙酸氟替卡松吸入治疗儿童感染后咳嗽(PIC)的应用价值。方法将96例PIC患儿按抽签法随机分为观察Ⅰ组,观察Ⅱ组和对照组。对照组(n=30)予氨溴特罗口服液治疗。观察I组(n=38)在上述常规治疗基础上,予孟鲁斯特咀嚼片及丙酸氟替卡松气雾剂治疗。观察Ⅱ组(n=28)予常规治疗+孟鲁斯特咀嚼片治疗。三组患者治疗10 d后,比较三组间的疗效。结果三组的总有效率分别为92.1%,75%,46.7%。观察组优于对照组(P<0.05),观察Ⅰ组优于观察Ⅱ组(P<0.05)。结论孟鲁斯特联合丙酸氟替卡松吸入治疗PIC的疗效显著。
作者 赵艳梅
出处 《临床军医杂志》 CAS 2014年第2期206-207,共2页 Clinical Journal of Medical Officers
  • 相关文献

参考文献5

二级参考文献106

共引文献1026

同被引文献67

  • 1杜晓华,张力燕,王华,范木英.孟鲁斯特联合布地奈德治疗感染后咳嗽的临床分析[J].昆明医科大学学报,2012,33(5):124-126. 被引量:13
  • 2黄英,陈坤华,石田田,刘恩梅.丙酸氟替卡松防治婴幼儿哮喘肺功能与临床观察[J].临床儿科杂志,2004,22(12):816-818. 被引量:9
  • 3中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案)[J].中华结核和呼吸杂志,2005,28(11):738-744. 被引量:1456
  • 4Han J, Jia Y,Takeda K,et d.Montelukast during primary infection prevents airway hyperresponsiveness and infla- mmation after reinfection with respiratory syncytial virus[J]. Am J Respir Crit Care Med,2010,182(4) :455-463.
  • 5Carlsen KC, Stick S, Kamin W, et al. The efficacy and safety of fluticasone propionate in very young children with persistent asthma symptoms. Respir Med, 2005, 99(11):1393-402.
  • 6Merchant JM, Masters IB, Taylor SM, et al. Evaluation and outcome of young children with chronic cough. Chest, 2006, 129(5): 1132- 1141.
  • 7Chu W, Campbeii JA, Rino JG, et al. Inhaied fiuticasone propionate reduces concentration of Mycopiasms pneumoniae infiammation and bronchiai hyperresponsiveness in iungs of mice. J Infect Dis,2004, 189(6):1119-1127.
  • 8Depasquale R,Lee SL,Saluja B,et al. The influence of secondary processing on the structural relaxation dynamics of fluticasonepropionate[J].AAPS Pharm Sci Tech,2015 ,16 ( 3 ) : 589-600.
  • 9Mehta R,Riddell K, Gupta A,et al. Comparison of the Pharmacokinetics of Salmeterol and FluticasonePropionate 50/100 μg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler[J]. Clinical Drug Investigation, 2015,35 (5) :319-326.
  • 10Mehta R, Daley-Yates PT, Jenkins K,et al. Pharmacokinetics of fluticasonepropionate and salmeterol delivered as a combination dry powder via a capsule-based inhaler and a multi-dose inhaler[J]. Pulmonary Pharmacology & Therapeutics ,2014,29 ( 1 ) :66-73.

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部